PH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Buy PH now. The stock is in a confirmed uptrend (bullish MA stack), just pulled back close to the key pivot/support (~937) after strong earnings and higher FY26 growth guidance. Options flow is more bullish on volume (put-call 0.49) and Wall Street is actively raising targets, supporting near-term continuation despite a slightly negative (but improving) MACD.
Trend: Bullish. Moving averages are stacked positively (SMA_5 > SMA_20 > SMA_200), which signals an established uptrend. Momentum: Mixed but not broken. RSI(6)=63.75 (neutral-to-strong, not overbought). MACD histogram is negative (-2.324) but is negatively contracting, suggesting downside momentum is fading rather than accelerating. Levels: Pivot/support at 937.286 is the key near-term line. If price holds above it, the next upside levels are R1 957.761 then R2 970.411. Near-term pattern odds (given): ~60% chance of -0.65% next day, +1.42% next week, -2.58% next month—implies some choppiness, but the weekly bias remains positive.
Intellectia Proprietary Trading Signals
Fiscal 2026/Q2 results beat expectations (Adj. EPS 7.65 reported vs 7.17 consensus cited); record Q2 sales $5.2B (+9% YoY); raised FY26 sales/organic growth outlook (to ~5.5%-7.5% range per reports); strong orders/execution commentary from analysts; acquisition of Filtration Group adds strategic/portfolio catalyst; multiple post-earnings price target increases (broad Street support).
Latest quarter showed YoY net income and EPS decline despite revenue growth (profitability mix/timing risk); near-term technical overhead resistance around ~958-970; distributor survey commentary (tariffs/local economics/inflation) flagged as demand headwinds by a Hold-rated analyst; open-interest put-call >1.0 indicates notable hedging still present; pattern-based next-month bias in provided stats is slightly negative (-2.58%).
Latest quarter: 2026/Q2. Revenue grew to $5.174B (+9.10% YoY), showing solid top-line momentum. Profit metrics softened YoY with Net Income at $845M (-10.92% YoY) and EPS at 6.6 (-8.97% YoY). However, Gross Margin improved to 37.32% (+2.25% YoY), indicating underlying pricing/mix and efficiency strength even as bottom-line comparisons dipped.
Recent trend: Clearly improving. Multiple firms raised price targets after the Q2 report while maintaining positive ratings—Barclays to $1,020 (Overweight), Citi to $1,092 (Buy), Goldman to $1,032 (Buy), JPMorgan to $1,083 (Overweight), Wells Fargo to $1,000 (Overweight), KeyBanc to $1,050 (Overweight). Stifel remains the notable cautious voice with Hold (raised PT to $941 from $869 earlier), citing distributor checks and macro/tariff/inflation frictions. Wall Street pros: strong order trends, execution, raised guidance, favorable cycle timing, and margin expansion narrative. Wall Street cons: pockets of demand sensitivity (tariffs/local economic conditions), and mixed near-term comparisons in net income/EPS.
